Role of TGFbeta signaling in skin carcinogenesis.
The TGFbeta signaling pathway is one of the most important mechanisms in the maintenance of epithelial homeostasis. Alterations leading to either the repression or enhancement of this pathway have been shown to affect cancer development. Although TGFbeta inhibits growth of normal epithelial cells, it is paradoxically overexpressed in many epithelial cancers. It has been postulated that TGFbeta acts as a tumor suppressor at the early stages of carcinogenesis, but overexpression of TGFbeta at late stages of carcinogenesis may be a critical factor for tumor invasion and metastasis. The detailed mechanisms regulating this functional switch of TGFbeta remain to be elucidated. The relevance of the TGFbeta signaling pathway to the development of primary epithelial tumors in man has been further substantiated by the discovery of mutations in TGFbeta receptors and in the downstream signaling mediators, the Smads. The epidermis is one of the major targeting tissues for TGFbeta signaling. Chemical carcinogenesis studies have revealed a paradoxical effect of TGFbeta on skin carcinogenesis: inhibition of papilloma formation but promotion of malignant conversion. In addition, deletion of the TGFbeta type II receptor accelerates skin carcinogenesis. This review focuses on our current understanding of the role of TGFbeta signaling in skin carcinogenesis.
Wang
X J
XJ
Departments of Dermatology, Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 77030, USA. xwang@bcm.tmc.edu
D000818:Animals; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D051379:Mice; D018125:Receptors, Transforming Growth Factor beta / Q000235:genetics / Q000378:metabolism; D015398:Signal Transduction; D012878:Skin Neoplasms / Q000276:immunology / Q000378:metabolism / Q000503:physiopathology*; D016212:Transforming Growth Factor beta / Q000378:metabolism*
D018125:Receptors, Transforming Growth Factor beta; D016212:Transforming Growth Factor beta